UEEC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
UEEC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-11), United Health Products's share price is $0.06043. United Health Products's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.01. Therefore, United Health Products's PE Ratio (TTM) for today is At Loss.
The historical rank and industry rank for United Health Products's PE Ratio (TTM) or its related term are showing as below:
United Health Products's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was $-0.00. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.01.
As of today (2024-12-11), United Health Products's share price is $0.06043. United Health Products's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.01. Therefore, United Health Products's PE Ratio without NRI for today is At Loss.
United Health Products's EPS without NRI for the three months ended in Sep. 2024 was $-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.01.
During the past 3 years, the average EPS without NRI Growth Rate was 51.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 10.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was -10.00% per year.
During the past 13 years, United Health Products's highest 3-Year average EPS without NRI Growth Rate was 51.60% per year. The lowest was -139.90% per year. And the median was -2.70% per year.
United Health Products's EPS (Basic) for the three months ended in Sep. 2024 was $-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.01.
The historical data trend for United Health Products's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Health Products Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
PE Ratio (TTM) | Get a 7-Day Free Trial | At Loss | At Loss | At Loss | At Loss | At Loss |
United Health Products Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
PE Ratio (TTM) | Get a 7-Day Free Trial | At Loss | At Loss | At Loss | At Loss | At Loss |
For the Medical Instruments & Supplies subindustry, United Health Products's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, United Health Products's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where United Health Products's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
United Health Products's PE Ratio (TTM) for today is calculated as
PE Ratio (TTM) | = | Share Price | / | Earnings per Share (Diluted) (TTM) |
= | 0.06043 | / | -0.005 | |
= | At Loss |
United Health Products's Share Price of today is $0.06043.
United Health Products's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PE Ratio (TTM) | = | Market Cap | / | Net Income |
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
United Health Products (OTCPK:UEEC) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.
Be Aware
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Thank you for viewing the detailed overview of United Health Products's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.
Brian David Thom | officer: CEO | 10624 S EASTERN AVE., STE A209, HENDERSON NV 89052 |
Kristofer Heaton | officer: Vice-President Finance, CFO | 526 COMMERCE CIRCLE, STE 120, MESQUITE NV 89027 |
Nate Knight | director | C/O MORSE & MORSE, PLLC, 1400 OLD COUNTRY ROAD, SUITE 302, WESTBURY NY 11590 |
Louis Schiliro | officer: Chief Operating Officer | 10624 S. EASTERN AVENUE, STE. A209, HENDERSON NV 89052 |
Douglas K Beplate | officer: CEO | |
Robert J. Denser | director | 10624 S. EASTERN AVE., STE. A209, HENDERSON NV 89052 |
John Vito Capotorto | director | 1090 KING GEORGES POST ROAD, SUITE 501, EDISON NJ 08837 |
Sherman Lazrus | director | |
Rodney Paul Leibowitz | director | 420 EAST 54TH STREET, APARTMENT 15B, NEW YORK NY 10022 |
Michael R. Wiechnik | director | 11 PRESWICK DR., MEDFORD NJ 08055 |
Richard Rifenburgh | director | 2637 E. ATLANTIC BLVD., #133, POMPANO BEACH FL 33062 |
Phillip David Forman | director, officer: President, Chairman and CEO | 1090 KING GEORGES POST RD,501, EDISON NJ 08837 |
Jan E Chason | director, officer: Chief Financial Officer | 120 WALL STREET, SUITE 2401, NEW YORK NY 10005 |
Kelly Thomas Hickel | director, officer: Chief Executive Officer | 1630A 30TH STREET, SUITE 300, BOULDER CO 80301 |
Patrick Donelan | 10 percent owner | 3570 LAKEVIEW DRIVE, DELRAY BEACH FL 33445 |
From GuruFocus
By Marketwired Marketwired • 11-04-2019
By Marketwired Marketwired • 10-09-2019
By Marketwired Marketwired • 10-04-2019
By Marketwired Marketwired • 07-09-2018
By Marketwired Marketwired • 09-06-2019
By Marketwired Marketwired • 08-14-2019
By GlobeNewswire GlobeNewswire • 10-09-2019
By Marketwired Marketwired • 06-19-2018
By ACCESSWIRE ACCESSWIRE • 06-28-2021
By Marketwired Marketwired • 11-06-2019
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.